Buy TRIAZAVIRIN capsules 250 mg 20 pcs
  • Buy TRIAZAVIRIN capsules 250 mg 20 pcs


Medical synthesis
35 Items
Dosage form
Brand & Manufacturer
Package Size
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology


The active ingredient of the drug Triazavirin® is a synthetic analogue of the bases of purine nucleosides (guanine) with a pronounced antiviral effect. It has a wide spectrum of antiviral activity against RNA-containing viruses.

The main mechanism of action of the drug Triazavirin® is the inhibition of the synthesis of viral RNA and the replication of genomic fragments.


After ingestion is rapidly absorbed in the gastrointestinal tract. Maximum concentration (Cthatx) is achieved on average in 1-1.5 hours. Cmaxat) the recommended dosing regimen averages 4.8 mcg / ml. The blood AUC (area under the pharmacokinetic curve "concentration - time") of blood is 12.8 mcg / h * ml. Elimination half-life (ti/2) - 1-1.5 hours

From 15 to 45% of the drug is excreted by the kidneys in unchanged form. The average calculated clearance is 246 ml / min.


Treatment of influenza in adults. If necessary, combined with the reception of symptomatic agents.


Active substance:

Methylthionitrooxodihydro-triazolotriazinide sodium dihydrate (triazavirin) - 250 mg.


Calcium stearate - 2 mg;

The mass of the contents of the capsule - 252 mg;

The composition of the shell of capsules:

Capsule (case) No. 1: titanium dioxide (E171), yellow quinoline (E104), yellow “sunset” (E110), medical gelatin.

Capsule (cap) No. 1: titanium dioxide (E171), azorubine (E122), medical gelatin.

The mass of the capsule with the contents - 328 mg

No customer reviews for the moment.

Write your review

Write your review


Dosage and Administration

Triazavirin® is applied inside regardless of the meal.

Therapeutic doses

The drug should be started no later than the 2nd day from the onset of the disease (onset of clinical symptoms) 1 capsule (250 mg) 3 times a day (daily dose 750 mg) for 5 days. If necessary, treatment can be continued up to 7 days.

Adverse reactions

allergic reactions;

  • part of the digestive system: dyspeptic disorders (flatulence, diarrhea, nausea, vomiting).

If any of the side effects indicated in the instruction are aggravated, or you have noticed any other side effects that are not indicated in the instruction, inform your doctor.


  • hypersensitivity to the drug;

  • pregnancy;

  • breastfeeding period;

  • children's age up to 18 years (efficiency and safety are not defined);

  • renal / hepatic impairment (efficacy and safety not determined).

Drug interactions

Interaction with analogues of purine and pyrimidine bases during antitumor therapy may lead to increased drug toxicity. With simultaneous use with ribavirin, ribavirin dose reduction is required.

Pregnancy and Lactation

The use of the drug during pregnancy has not been studied.

The use of the drug during lactation has not been studied, therefore, if necessary, use of the drug during lactation should stop breastfeeding.


Symptoms: nausea, vomiting, dyspeptic disorders, stomach pain.

Treatment: symptomatic therapy. When these symptoms appear, you must stop taking the drug.

  • Brand name: TRIAZAVIRIN
  • Active ingredient: Methylthionitroxodihydro-triazolotriazinide sodium
  • Dosage form: Capsules
  • Manufacturer: Medical synthesis
  • Country of Origin: Russia

Customers who bought this product also bought:

8 other products in the same category: